Artificial intelligence (AI) software developer RapidAI has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Rapid PE Triage & Notification software platform.
Rapid PE Triage & Notification is designed to identify suspected cases of central pulmonary embolism (PE) on CT pulmonary angiography exams and provide real-time notifications to physicians, according to the vendor.
